Greencamp

FEBRUARY 17, 2019

One study from 2004 looked at cannabinoids as a treatment option for managing bowel diseases symptoms (including IBS), because of their anti-inflammatory properties, but also the ability to diminish pain levels. According to the studies on cannabis and IBS, both high-THC and high-CBD strains have the potential to relieve symptoms.

Digestion 96

Digestion Research and Development Marijuana Cannabinoids 96

Greencamp

AUGUST 16, 2018

This is how the psychoactive intoxication with THC affects our brain, and this same pathway is activated for the many other medical benefits cannabis has to offer. Also presented in the American Journal of Hospice and Palliative Care, a 2004 survey set about to discover the effect of cannabis use on ALS in humans.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Greencamp

FEBRUARY 2, 2019

Even though scientific data is still somewhat scarce on this topic, several studies confirm that cannabis directly acts on the cells of the immune system affected by HIV. It will be the biggest and most comprehensive research on this topic to date, and it will include 400 HIV patients from Florida. 2016 ( 3 ). 2007 ( 6 ).

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

The Cannigma

JANUARY 13, 2023

Based on the limited existing evidence, the best cannabis strain for migraines may be a Type II that includes both THC and CBD, and a terpene profile that includes beta-caryophyllene, myrcene, linalool, limonene, bisabolol, humulene or pinene. Edibles won’t produce the same experience, but topicals may be able to help, too.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

NOVEMBER 24, 2021

It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). The recreational use of cannabis is well known and attributed to its power as a psychotropic plant, specifically due to the cannabinoid tetrahydrocannabinol (THC). 2016 ; Sznitman et al. years (Atakan 2012 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73